Life Sciences & Pharma Investment Sales | Carolinas

We advise owners and investors on the sale and acquisition of pharmaceutical-

, life sciences-, and healthcare-occupied industrial and flex assets where income

durability is driven by operational relevance, not short-term yield.

Our investment advisory services include:

• Sale of healthcare- and pharma-occupied industrial and flex assets
• Life sciences manufacturing and distribution facilities
• Cold-chain and specialized logistics properties
• Off-market and confidential transaction execution
• Buyer targeting and pricing strategy
• Use-, tenancy-, and infrastructure-driven risk analysis

Our approach emphasizes quiet execution, disciplined pricing, long-term cash flow durability, and enterprise-level alignment.

Investment performance in this segment depends on:

• Use specificity
• Infrastructure dependency
• Tenant operational stickiness
• Regulatory exposure

We price and position assets based on how they actually function, not just cap-rate assumptions, and coordinate with internal governance teams for large-cap or enterprise clients.

If you own or are evaluating a pharmaceutical, life sciences, or healthcare industrial asset, we can help you execute with discretion, clarity, and enterprise alignment.

Contact us to start the conversation.